FLT4 and cancer: MAZ51 also has anti-angiogenic effects and directly suppresses tumor cell growth and progression in rat carcinoma cells and in oral squamoid cancer cells via inhibition of the VEGF-C/VEGFR-3 axis [3], [8], [10].